Michael Chuong is radiation oncologist specializing in the treatment of gastrointestinal cancer, head and neck cancer and hematologic malignancies. He treats patients utilizing state-of-the-art radiation therapies, including proton therapy — a highly advanced form of radiation technology that targets cancer cells with pencil-beam scanning precision while sparing the surrounding healthy tissue. Chuong is actively involved in sponsored clinical research and has received several awards for his work. He serves as an editorial reviewer for numerous peer-reviewed medical journals. He also is widely published and an invited presenter at national and international scientific symposiums.
Research Interests
- Ablative MRI-guided radiation therapy for inoperable pancreatic cancer
- Ablative MRI-guided radiation therapy for oligometastatic colorectal cancer
- Proton therapy for liver cancer
- Radiation therapy and immunotherapy combinations
See research publications and more on FIU Discovery.
Honors & Awards
- C2X Award, University of Maryland, 2015
- Merit Award, American Society of Clinical Medicine Conquer Cancer Foundation, 2013
- Clinical Research Award, Moffitt Cancer Center Research Symposium, 2011
- Resident Travel Award, American Brachytherapy Society Annual Meeting, 2011
Committees & Professional Organization
- American Society for Radiation Oncology
- Proton Collaborative Group
- Particle Therapy Cooperative Group
Education
- M.D., University of South Florida, Tampa, FL, 2008
- BA, Brandeis University, Waltham, MA 2004
Board Certifications
- American Board of Radiology